Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation

The RelA/cRel nuclear factor-κB (NF-κB) dimer, crucial for inflammation resolution, mediates the transcription of the key enzyme in melatonin synthesis in RAW 264.7 macrophages

(2016) Sandra Marcia Muxel et al.   JOURNAL OF PINEAL RESEARCH

Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)

(2015) Cheng Jun Jin et al.   BRITISH JOURNAL OF NUTRITION

Effects of oral butyrate application on insulin signaling in various tissues of chickens

(2015) G. Mátis et al.   DOMESTIC ANIMAL ENDOCRINOLOGY

Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis

(2015) Cathrin Sellmann et al.   JOURNAL OF NUTRITION

Melatonin: an ancient molecule that makes oxygen metabolically tolerable

(2015) Lucien C. Manchester et al.   JOURNAL OF PINEAL RESEARCH

Treatment of Non-Alcoholic Fatty Liver Disease

(2014) Jessica Dyson et al.   DIGESTIVE DISEASES

Sodium butyrate protects against toxin-induced acute liver failure in rats

(2014) Fan Yang et al.   Hepatobiliary & Pancreatic Diseases International

Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges

(2014) Etsuko Hashimoto et al.   HEPATOLOGY RESEARCH

The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system

(2014) Thaher Pelaseyed et al.   IMMUNOLOGICAL REVIEWS

Melatonin: a well-documented antioxidant with conditional pro-oxidant actions

(2014) Hong-Mei Zhang et al.   JOURNAL OF PINEAL RESEARCH

Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis

(2014) Timea Csak et al.   LIVER INTERNATIONAL

Butyrate Protects Rat Liver against Total Hepatic Ischemia Reperfusion Injury with Bowel Congestion

(2014) Bin Liu et al.   PLoS One

Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions1

(2013) X. Ma et al.   JOURNAL OF ANIMAL SCIENCE

The burden of liver disease in Europe: A review of available epidemiological data

(2013) Martin Blachier et al.   JOURNAL OF HEPATOLOGY

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease

(2013) Giridhar Kanuri et al.   LIVER INTERNATIONAL

Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis

(2013) Hitoshi Endo et al.   PLoS One

Effects of Sodium Butyrate and Its Synthetic Amide Derivative on Liver Inflammation and Glucose Tolerance in an Animal Model of Steatosis Induced by High Fat Diet

(2013) Giuseppina Mattace Raso et al.   PLoS One

Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice

(2012) Marco Aurélio Ramirez Vinolo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Butyrate

(2012) Alda J. Leonel et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

(2012) Valentina Volynets et al.   DIGESTIVE DISEASES AND SCIENCES

Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription

(2012) Hong-Bo Wang et al.   DIGESTIVE DISEASES AND SCIENCES

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

(2012) Astrid Spruss et al.   LABORATORY INVESTIGATION

Butyrate Attenuates Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa through Modulation of Antioxidant Defense Machinery

(2012) Ilaria Russo et al.   PLoS One

The epigenetic effects of butyrate: potential therapeutic implications for clinical practice

(2012) Roberto Berni Canani et al.   Clinical Epigenetics

Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis

(2011) Sabine Wagnerberger et al.   BRITISH JOURNAL OF NUTRITION

Role of the Inducible Nitric Oxide Synthase in the Onset of Fructose-Induced Steatosis in Mice

(2010) Astrid Spruss et al.   ANTIOXIDANTS & REDOX SIGNALING

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice

(2009) Synia Haub et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice

(2009) Astrid Spruss et al.   HEPATOLOGY

Role of copper,zinc-superoxide dismutase in catalyzing nitrotyrosine formation in murine liver

(2008) Jian-Hong Zhu et al.   FREE RADICAL BIOLOGY AND MEDICINE